|
⚲
|
| Keyboard |
| HealthCap VII LP
✚
|
|
|---|---|
| CIK # | 0001645161 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001645161] | |
| 4 | [0001645161] | |
| D | [0001645161] | |
| SC 13D | [0001645161] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| HealthCap VII LP | Carisma Therapeutics Inc | [2023-03-09] |
| HealthCap VII LP | Fusion Pharmaceuticals Inc | [2020-07-10] |
| HealthCap VII LP | Aprea Therapeutics Inc | [2019-10-17] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| HealthCap VII GP SA | |
| HealthCap VII LP | |
| Fusion Pharmaceuticals Inc | |
| Aprea Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Fusion Pharmaceuticals Inc FUSN
Class A Preferred Exchangeable Shares · derivative
|
2020-06-30 | Conversion | 13,333,333 | ||
|
Fusion Pharmaceuticals Inc FUSN
Common Shares
|
2020-06-30 | Conversion | 2,497,345 | ||
|
Fusion Pharmaceuticals Inc FUSN
Common Shares
|
2020-06-30 | Conversion | 1,069,902 | ||
|
Fusion Pharmaceuticals Inc FUSN
Common Shares
|
2020-06-30 | Buy | 240,000 | $17.00 | 4,080,000 |
|
Fusion Pharmaceuticals Inc FUSN
Class B Preferred Exchangeable Shares · derivative
|
2020-06-30 | Conversion | 5,712,216 | ||
|
Aprea Therapeutics Inc APRE
Common Stock
|
2019-10-07 | Buy | 266,667 | $15.00 | 4,000,005 |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2019-10-07 | Conversion | 427,496 | ||
|
Aprea Therapeutics Inc APRE
Common Stock
|
2019-10-07 | Conversion | 1,661,382 | ||
|
Aprea Therapeutics Inc APRE
Series C Convertible Preferred Stock · derivative
|
2019-10-07 | Conversion | 427,496 | ||
|
Aprea Therapeutics Inc APRE
Series B Convertible Preferred Stock · derivative
|
2019-10-07 | Conversion | 1,661,382 |